Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 122 participants.
Also called NCT06645249
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 122 participants
- Registry
-
NCT06645249 -
2023-507201-34-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06645249. Randomized; no masking; primary purpose treatment. Start 2024-12-10 (anticipated); primary completion 2026-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation
- Acronym
- PERIVERSION
- Condition
- Atrial Fibrillation (AF)
- Intervention (Drug)
- Amiodarone (Antiarrhythmic drug)
- Lead sponsor
- Institut Investigacio Sanitaria Pere Virgili
- Collaborator
- Spanish Society of Cardiology
- Collaborator
- Sociedad Espanola de Cardiologia
Record details
- Record id
cardio:ct-nct06645249- Content hash
06262df584b4e31d94c90a037ae0078c4a91a5912a972a51da2bec70b89abd33